Skip to content
Health News Digest.
Menu
Menu

How a Potential Diabetes Treatment Flips its Molecular Switch

Posted on April 17, 2012

emory-healthcare_53_30.jpg

(HealthNewsDigest.com) – ATLANTA–A trace component of lecithin called DLPC (dilauroyl phosphatidylcholine) was recently discovered to have antidiabetic properties in animals. When fed to diabetic mice, DLPC could increase insulin sensitivity and reduce fat accumulation in the liver.

Now scientists at Emory University School of Medicine have obtained a detailed molecular picture of how DLPC fits into LRH-1, the protein sensor that triggers its effects. The information gives hints about how beneficial dietary fats regulate metabolism and could help researchers tweak DLPC to work best in humans.

The results were published online April 15 in the journal Nature Structural & Molecular Biology.

Read more: http://bit.ly/DLPCantidiabeticproperties

Interact with Emory Health Sciences: http://bit.ly/emoryhealthscisocial

###

For advertising and promotion on HealthNewsDigest.com please contact Mike McCurdy: [email protected] or 877-634-9180
HealthNewsDigest.com is syndicated worldwide, and our content is free to all media. www.HealthNewsDigest.com

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Archive

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Newsletter
For Email Marketing you can trust

Recent Posts

  • As Foundation for ‘Excited Delirium’ Diagnosis Cracks, Fallout Spreads
  • Millions in Opioid Settlement Funds Sit Untouched as Overdose Deaths Rise
  • Sign Up for Well’s 6-Day Energy Challenge
  • William P. Murphy Jr., Innovator of Life-Saving Medical Tools, Dies at 100
  • How Abigail Echo-Hawk Uses Indigenous Data to Close the Equity Gap

Recent Comments

No comments to show.

Archives

Categories

©2025 Health News Digest. | Design: Newspaperly WordPress Theme